We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$752M
AUM Growth
+$253M
Cap. Flow
+$268M
Cap. Flow %
35.64%
Top 10 Hldgs %
9.6%
Holding
1,082
New
405
Increased
619
Reduced
41
Closed
17

Top Buys

Rank Stock Value
1
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
+$17.4M
2
AAPL icon
Apple
AAPL
+$7.52M
3
AVGO icon
Broadcom
AVGO
+$6.81M
4
BHC icon
Bausch Health
BHC
+$5.93M
5
NBIS
Nebius Group N.V.
NBIS
+$4.82M

Top Sells

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$2.86M
2
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
+$1.98M
3
EGLE
Eagle Bulk Shipping Inc.
EGLE
+$1.84M
4
ALTR
Altera Corp
ALTR
+$1.74M
5
PCYC
PHARMACYCLICS INC
PCYC
+$1.64M

Sector Composition

Rank Sector Weight
1 Technology 15.2%
2 Healthcare 13.08%
3 Industrials 11.83%
4 Financials 9.36%
5 Consumer Discretionary 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TFM
201
DELISTED
THE FRESH MARKET, INC COM STK
TFM
$1.03M 0.14%
32,080
+1,540
+5% +$53.9K
MR
202
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
$1.03M 0.14%
+36,126
New +$1.05M
CSC
203
DELISTED
Computer Sciences
CSC
$1.03M 0.14%
37,123
+3,666
+11% +$103K
SYKE
204
DELISTED
SYKES Enterprises Inc
SYKE
$1.02M 0.14%
42,143
+2,018
+5% +$49.9K
VAR
205
DELISTED
Varian Medical Systems, Inc.
VAR
$1.01M 0.13%
+13,673
New +$1.07M
GMED icon
206
Globus Medical
GMED
$11B
$992K 0.13%
38,646
+1,766
+5% +$44.7K
MSFT icon
207
Microsoft
MSFT
$3.71T
$970K 0.13%
21,973
-29,944
-58% -$1.37M
JNJ icon
208
Johnson & Johnson
JNJ
$619B
$967K 0.13%
9,920
+760
+8% +$76.1K
BR icon
209
Broadridge
BR
$18.8B
$966K 0.13%
19,326
+883
+5% +$47K
PBF icon
210
PBF Energy
PBF
$7.26B
$966K 0.13%
34,005
+1,561
+5% +$43.9K
WFM
211
DELISTED
Whole Foods Market Inc
WFM
$966K 0.13%
24,485
+1,775
+8% +$79.4K
INGR icon
212
Ingredion
INGR
$6.49B
$958K 0.13%
11,999
+583
+5% +$46.8K
GEN icon
213
Gen Digital
GEN
$16.8B
$949K 0.13%
40,810
+3,061
+8% +$74.7K
USNA icon
214
Usana Health Sciences
USNA
$275M
$949K 0.13%
13,892
+674
+5% +$42.8K
XONE
215
DELISTED
The ExOne Company
XONE
$939K 0.12%
+84,580
New +$1.13M
PRGS icon
216
Progress Software
PRGS
$1.71B
$936K 0.12%
34,054
+1,572
+5% +$41.9K
SEB icon
217
Seaboard Corp
SEB
$4.1B
$936K 0.12%
260
+13
+5% +$46.5K
GLP icon
218
Global Partners
GLP
$1.65B
$927K 0.12%
28,564
+1,507
+6% +$57.7K
ELV icon
219
Elevance Health
ELV
$84.9B
$925K 0.12%
5,638
+389
+7% +$62.2K
NUS icon
220
Nu Skin
NUS
$252M
$918K 0.12%
19,487
+893
+5% +$48.3K
AHGP
221
DELISTED
Alliance Holdings GP
AHGP
$916K 0.12%
23,388
+1,078
+5% +$51.5K
VTA
222
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$912K 0.12%
+78,553
New +$949K
MODV
223
DELISTED
ModivCare
MODV
$876K 0.12%
19,788
+918
+5% +$43.6K
AFSI
224
DELISTED
AmTrust Financial Services, Inc.
AFSI
$874K 0.12%
26,696
+1,244
+5% +$37.5K
ACN icon
225
Accenture
ACN
$105B
$870K 0.12%
8,994
+745
+9% +$71.2K
7 8
9
10 11

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q2 2015 Portfolio in Review

As of Q2 2015, Vident Investment Advisory held 1,082 positions worth $752M, up 51% from $498M the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Vident Investment Advisory deployed $268M of net new capital in Q2 2015, opening 405 new positions and adding to 619 existing holdings. Its largest new stake was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $2.86M trimmed.

  • Vident Investment Advisory's largest Q2 2015 buy was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.
  • Vident Investment Advisory added most to Apple in Q2 2015, an estimated $7.52M increase.
  • Vident Investment Advisory's biggest Q2 2015 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $2.86M.
  • Vident Investment Advisory fully exited AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2015, selling an estimated $1.98M.
  • Vident Investment Advisory's ten largest holdings make up 9.6% of its $752M portfolio in Q2 2015.
  • Vident Investment Advisory opened 405 new positions and closed 17 in Q2 2015.
  • Vident Investment Advisory's portfolio value rose 51% quarter-over-quarter to $752M.

Based on Vident Investment Advisory's 13F filing for Q2 2015, filed 29 Jul 2015.